发明名称 PHARMACEUTICAL COMPOSITION
摘要 <P>PROBLEM TO BE SOLVED: To provide a medicine useful for prevention and treatment of cardiac arrhythmia such as atrial fibrillation and the like. <P>SOLUTION: The medicine is composed of a compound represented by the general formula or a pharmaceutically acceptable salt thereof. In the formula, the ring X is benzene or pyridine; R<SP POS="POST">1</SP>is optionally substituted alkyl; R<SP POS="POST">2</SP>is optionally substituted aryl, an optionally substituted heterocyclic group, optionally substituted arylalkyl or alkyl substituted with an optionally substituted heterocyclic group. R<SP POS="POST">3</SP>, R<SP POS="POST">4</SP>, R<SP POS="POST">5</SP>, R<SP POS="POST">6</SP>, R<SP POS="POST">7</SP>, R<SP POS="POST">8</SP>and R<SP POS="POST">9</SP>are each hydrogen or alkyl; R<SP POS="POST">3</SP>and R<SP POS="POST">5</SP>may be linked to form a cycloalkyl group together with a neighboring carbon atom; and m is 0 or 1. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012067036(A) 申请公布日期 2012.04.05
申请号 JP20100213280 申请日期 2010.09.24
申请人 MITSUBISHI TANABE PHARMA CORP 发明人 YAMAGUCHI TETSUHISA;GOKOCHI HIDEKI;HIRAI MIKI;IMANISHI YASUHIRO
分类号 A61K31/416;A61K31/427;A61K31/437;A61K31/4709;A61K31/5377;A61K31/538;A61P7/02;A61P9/04;A61P9/06;A61P9/10;A61P43/00;C07D231/56;C07D417/12;C07D471/04 主分类号 A61K31/416
代理机构 代理人
主权项
地址